Granisetron Transdermal Patch System for Prevention of CINV by CapeOX
Clinical trial NCT05325190 · UNKNOWN
Trial details
- NCT number
- NCT05325190
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-10
- Primary completion
- 2022-12-30
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.